Review Article| Volume 17, ISSUE 5, P800-810, September 1995

Download started.


A review of the causes and treatment of bacterial and allergic conjunctivitis

  • Mitchell H. Friedlaender
    Addres correspondence to: Mitchell H. Friedlander, MD, Division of Ophthalmology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
    Division of Ophthalmology, Scripps Clinic and Research Foundation, La Jolla, California U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.


      The most common causes of ocular inflammation are allergic or infectious in origin. A presumptive diagnosis can often be made through a comprehensive patient history and evaluation of presenting signs and symptoms, although the constellation and intensity of clinical findings may vary. Patients with allergic conjunctivitis often have itchy, red eyes, whereas patients with bacterial conjunctivitis often give a history of morning crusting and difficulty opening the eyelids. The treatment of patients with allergic conjunctivitis includes avoiding the offending allergen and applying topical antihistamines, mast cell stabilizers, or nonsteroidal anti-inflammatory agents. Streptococcus pneumoniae and Haemophilus influenzae are responsible for most cases of bacterial conjunctivitis in children; Staphylococcus species is the predominant organism in adults. Therefore, the treatment of patients with bacterial conjunctivitis consists of an antimicrobial agent with a broad spectrum of activity against most susceptible pathogenus. Other causes of inflammation need to be considered in patients with atypical clinical signs and symptoms and in patients who do not respond to presumptive therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wagner RS
        Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution.
        Clin Ther. 1995; 17: 875-881
        • Raizman MB
        Results of a survey of patients with ocular allergy receiving treatment with topical ketorolac tromethamine.
        Clin Ther. 1995; 17: 882-890
        • Friedlander MH
        • Ohashi Y
        • Kelley J
        Diagnosis of allergic conjunctivitis.
        Arch Ophthalmol. 1984; 102: 1198-1199
        • Butrus SI
        • Abelson MB
        Laboratory evaluation of ocular allergy.
        Int Ophthalmol Clin. 1988; 28: 324-328
        • Abelson MB
        • Madiwale N
        • Weston JH
        Conjunctival eosinophils in allergic ocular disease.
        Arch Ophthalmol. 1983; 101: 555-556
        • Christiansen SC
        Evaluation and treatment of the allergic patient.
        Int Ophthalmol Clin. 1988; 28: 282-293
        • Holzberg M
        • Stulting RD
        • Drake LA
        Ocular and periocular infection.
        Dermatol Clin. 1992; 10: 741-761
        • Fedukowicz HB
        • Stenson S
        3rd ed. External Infections of the Eye: Bacterial, Viral, Mycotic with Noninfectious and Immunologic Diseases. Appleton-Century-Crofts, Norwalk, Conn1985: 88-90
        • Syed NA
        • Hyndiuk RA
        Infectious conjunctivitis.
        Infect Dis Clin North Am. 1992; 6: 789-805
        • Seal DV
        • Barrett SP
        • McGill JI
        Aetiology and treatment of acute bacterial infection of the external eye.
        Br J Ophthalmol. 1982; 66: 357-360
        • The American Academy of Ophthalmology
        Preferred Practice Pattern: Conjunctivitis. American Academy of Ophthalmology, San Francisco1991: 1-13
        • Abelson MB
        • Weston JH
        in: Lamberts DW Potter DE Clinical Ophthalmic Pharmacology. Little, Brown & Co, Boston1987: 417-424
        • Collum LMT
        A three-month clinical evaluation of topical lodoxamide tromethamine for the control of allergic conjunctivitis.
        Presented at the 26th International Congress of Ophthalmology, Singapore. 18241990; (Abstract SP-177)
        • Abelson MB
        • Schaefer K
        Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy.
        Surv Ophthalmol. 1993; 38 (Suppl): 115-132
        • Tinkelman DG
        • Rupp G
        • Kaufman H
        • et al.
        Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
        Surv Ophthalmol. 1993; 38 (Suppl): 133-140
        • Ballas Z
        • Blumenthal M
        • Tinkelman DT
        • et al.
        Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
        Surv Ophthalmol. 1993; 38 (Suppl): 141-148
        • Fiscella R
        Ophthalmic infections.
        in: DiPiro JT Talbert RL Hayes PE Pharmacotherapy: A Pathophysiologic Approach. Elsevier, New York1992: 1577-1595
        • Gibson JR
        Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis—a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions.
        J Antimicrob Chemother. 1983; 11: 217-221
        • Friedlaender MH
        Corticosteroid therapy of ocular inflammation.
        Int Ophthalmol Clin. 1983; 23: 175-182
      1. Trimethoprim-polymyxin B for bacterial conjunctivitis.
        Med Lett Drugs Ther. 1990; 32 (Anonymous): 71-72
        • Chau PY
        • Leung YK
        • Ng WWS
        Comparative in vitro antibacterial activity of oflaxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
        Infection. 1986; 14 (Suppl): S237-S242
        • Osato MS
        • Jensen HG
        • Trousdale MD
        • et al.
        The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates.
        Am J Ophthalmol. 1989; 108: 380-386
        • Shungu DL
        • Tutlane VK
        • Weinberg E
        • Gadebusch HH
        In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
        Chemotherapy. 1985; 31: 112-118